fig1
![Sequential treatment with doxorubicin and zoledronic acid has no additive effects in an aggressive model of established bone metastases](https://image.oaes.cc/a94ce938-174e-41d4-8eb5-000aa30c0064/2988.fig.1.jpg)
Figure 1. Dosing schedule of the doxorubicin (DOX) + zoledronic acid (ZOL) group
Figure 1. Dosing schedule of the doxorubicin (DOX) + zoledronic acid (ZOL) group
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/